WNT signaling in ovarian follicle biology and tumorigenesis

Trends in Endocrinology and Metabolism

Volumn 21, Issue 1, 2010, Pages 25-32

  Boyer, Alexandre ^a   Goff, Alan K ^a   Boerboom, Derek ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BETA CATENIN 1; CARRIER PROTEINS AND BINDING PROTEINS; FRIZZLED PROTEIN; FRIZZLED PROTEIN 1; FRIZZLED PROTEIN 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; ROOF PLATE SPECIFIC SPONDIN 1; SECRETED FRIZZLED RELATED PROTEIN 4; UNCLASSIFIED DRUG; WNT PROTEIN; WNT4 PROTEIN;

CARCINOGENESIS; EMBRYO DEVELOPMENT; GENE EXPRESSION; GRANULOSA CELL TUMOR; HUMAN; LUTEINIZATION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVULATION; PARACRINE SIGNALING; PERINATAL PERIOD; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; FEMALE; FRIZZLED RECEPTORS; GRANULOSA CELL TUMOR; HUMANS; MALE; OVARIAN FOLLICLE; OVARIAN NEOPLASMS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 73249124003     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2009.08.005     Document Type: Review

References (82)

1. Huang H., and He X. Wnt/beta-catenin signaling: new (and old) players and new insights. Curr. Opin. Cell. Biol. 20 (2008) 119-125
2. Karner C., et al. Apical-basal polarity, Wnt signaling and vertebrate organogenesis. Semin. Cell. Dev. Biol. 17 (2006) 214-222
3. Reya T., and Clevers H. WNT signalling in stem cells and cancer. Nature 434 (2005) 843-850
4. Lee H.Y., et al. Instructive role of WNT/beta-catenin in sensory fate specification in neural crest stem cells. Science 303 (2004) 1020-1023
5. Muroyama Y., et al. WNT proteins promote neuronal differentiation in neural stem cell culture. Biochem. Biophys. Res. Commun. 313 (2004) 915-921
6. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 127 (2006) 469-480
7. Bodine P.V. Wnt signaling control of bone cell apoptosis. Cell Res. 18 (2008) 248-253
8. Reynolds A.B., and Roczniak-Ferguson A. Emerging roles for p120-catenin in cell adhesion and cancer. Oncogene 23 (2004) 7947-7956
9. Lustig B., and Behrens J. The Wnt signaling pathway and its role in tumor development. J. Cancer. Res. Clin. Oncol. 129 (2003) 199-221
10. Giles R.H., et al. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653 (2003) 1-24
11. Segditsas S., and Tomlinson I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 25 (2006) 7531-7537
12. Nemeth M.J., and Bodine D.M. Regulation of hematopoiesis and the hematopoietic stem cell niche by Wnt signaling pathways. Cell. Res. 17 (2007) 746-758
13. Yen T.H., and Wright N.A. The gastrointestinal tract stem cell niche. Stem Cell Rev. 2 (2006) 203-212
14. Vainio S., et al. Female development in mammals is regulated by Wnt-4 signalling. Nature 397 (1999) 405-409
15. Jeays-Ward K., et al. Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad. Development 130 (2003) 3663-3670
16. Heikkilä M., et al. Wnt-4 deficiency altersmouse adrenal cortex function, reducing aldosterone production. Endocrinology 143 (2002) 4358-4365
17. Ricken A., et al. Wnt signaling in the ovary; identification and compartmentalized expression of wnt-2, wnt-2b and frizzled-4 mRNAs. Endocrinology 143 (2002) 2741-2749
18. Wang H.X., et al. Identification of WNT/beta-CATENIN signaling pathway components in human cumulus cells. Mol. Hum. Reprod. 15 (2009) 11-17
19. Hernandez-Gonzalez I., et al. Gene expression profiles of cumulus cell oocyte complexes during ovulation reveal cumulus cells express neuronal and immune-related genes: does this expand their role in the ovulation process?. Mol. Endocrinol. 20 (2006) 1300-1321
20. Hsieh M., et al. Regulated expression of Wnts and Frizzleds at specific stages of follicular development in the rodent ovary. Endocrinology 143 (2002) 898-908
21. Wood J.R., et al. The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling. J. Reprod. Immunol. 63 (2004) 51-60
22. Oksjoki S., et al. Molecular profiling of polycystic ovaries for markers of cell invasion and matrix turnover. Fertil. Steril. 83 (2005) 937-944
23. Kenigsberg S., et al. Gene expression microarray profiles of cumulus cells in lean and overweight-obese polycystic ovary syndrome patients. Mol. Hum. Reprod. 15 (2009) 89-103
24. Harwood B.N., et al. Members of the WNT signaling pathways are widely expressed in mouse ovaries, oocytes, and cleavage stage embryos. Dev. Dyn. 237 (2008) 1099-1111
25. Boerboom D., et al. Misregulated Wnt/beta-catenin signaling leads to ovarian granulosa cell tumor development. Cancer Res. 65 (2005) 9206-9215
26. Davies B.R., et al. Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers. Histopathology 32 (1998) 69-80
27. Hsieh M., et al. Expression and localization of secreted frizzled-related protein-4 in the rodent ovary: evidence for selective up-regulation in luteinized granulosa cells. Endocrinology 144 (2003) 4597-4606
28. Monkley S.J., et al. Targeted disruption of the Wnt2 gene results in placentation defects. Development 122 (1996) 3343-3353
29. Hsieh M., et al. Mice null for Frizzled4 (Fzd4-/-) are infertile and exhibit impaired corpora lutea formation and function. Biol. Reprod. 73 (2005) 1135-1146
30. Boerboom D., et al. Dominant-stable β-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model. Cancer Res. 66 (2006) 1964-1973
31. Tomizuka K., et al. R-spondin1 plays an essential role in ovarian development through positively regulating Wnt-4 signaling. Hum. Mol. Genet. 17 (2008) 1278-1291
32. Chassot A.A., et al. Activation of beta-catenin signaling by Rspo1 controls differentiation of the mammalian ovary. Hum. Mol. Genet. 17 (2008) 1264-1277
33. Hernandez Gifford J.A., et al. Conditional deletion of beta-catenin mediated by Amhr2cre in mice causes female infertility. Biol. Reprod. 80 (2009) 1282-1292
34. Parma P., et al. R-spondin1 is essential in sex determination, skin differentiation and malignancy. Nat. Genet. 38 (2006) 1304-1309
35. Gordon M.D., and Nusse R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J. Biol. Chem. 281 (2006) 22429-22433
36. Kestler H.A., and Kühl M. From individual Wnt pathways towards a Wnt signalling network. Philos. Trans. R. Soc. Lond. B Biol. Sci. 363 (2008) 1333-1347
37. Kohn A.D., and Moon R.T. Wnt and calcium signaling: beta-catenin-independent pathways. Cell Calcium 38 (2005) 439-446
38. Tevosian S.G., and Manuylov N.L. To beta or not to beta: canonical beta-catenin signaling pathway and ovarian development. Dev. Dyn. 237 (2008) 3672-3680
39. Logan C.Y., and Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell. Dev. Biol. 20 (2004) 781-810
40. Kaidi A., et al. Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat. Cell. Biol. 9 (2007) 210-217
41. Manolagas S.C., and Almeida M. Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Mol. Endocrinol. 21 (2007) 2605-2614
42. Stark K., et al. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372 (1994) 679-683
43. Boerboom D. Paracrine signalling in the ovary: the role of Wnt. Endocr. Abstracts 19 (2009) S21
44. Jorgez C.J., et al. Granulosa cell-specific inactivation of follistatin causes female fertility defects. Mol. Endocrinol. 18 (2004) 953-967
45. Harada N., et al. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J. 18 (1999) 5931-5942
46. Arango N.A., et al. Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev. Biol. 288 (2005) 276-283
47. Parakh T.N., et al. Follicle-stimulating hormone/cAMP regulation of aromatase gene expression requires beta-catenin. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 12435-12440
48. Drake J.M., et al. The role of sFRP4, a secreted frizzled-related protein, in ovulation. Apoptosis 8 (2003) 389-397
49. Binnerts M.E., et al. R-Spondin1 regulates Wnt signaling by inhibiting internalization of LRP6. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 14700-21475
50. Kocer A., et al. R-spondin1 and FOXL2 act into two distinct cellular types during goat ovarian differentiation. BMC Dev. Biol. 8 (2008) 36
51. Wayne C.M., et al. Follicle-stimulating hormone induces multiple signaling cascades: evidence that activation of Rous sarcoma oncogene, RAS, and the epidermal growth factor receptor are critical for granulosa cell differentiation. Mol. Endocrinol. 21 (2007) 1940-1957
52. Hunzicker-Dunn M., and Maizels E.T. FSH signaling pathways in immature granulosa cells that regulate target gene expression: branching out from protein kinase A. Cell. Signal. 18 (2006) 1351-1359
53. Richards J.S., et al. Expression of FKHR, FKHRL1, and AFX genes in the rodent ovary: evidence for regulation by IGF-I, estrogen, and the gonadotropins. Mol. Endocrinol. 16 (2002) 580-599
54. Ongeri E.M., et al. Follicle-stimulating hormone induction of ovarian insulin-like growth factor-binding protein-3 transcription requires a TATA box-binding protein and the protein kinase A and phosphatidylinositol-3 kinase pathways. Mol. Endocrinol. 19 (2005) 1837-1848
55. Cross D.A., et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785-789
56. Desbois-Mouthon C., et al. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Oncogene 20 (2001) 252-259
57. Naito A.T., et al. Phosphatidylinositol 3-kinase-Akt pathway plays a critical role in early cardiomyogenesis by regulating canonical Wnt signaling. Circ. Res. 97 (2005) 144-151
58. Dash P.R., et al. Trophoblast apoptosis is inhibited by hepatocyte growth factor through the Akt and beta-catenin mediated up-regulation of inducible nitric oxide synthase. Cell. Signal. 17 (2005) 571-580
59. Tian Q., et al. Bridging the BMP and Wnt pathways by PI3 kinase/Akt and 14-3-3zeta. Cell Cycle 4 (2005) 215-216
60. Rochat A., et al. Insulin and wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy. Mol. Biol. Cell 15 (2004) 4544-4555
61. Haq S., et al. Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 4610-4615
62. Larue L., and Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene 24 (2005) 7443-7454
63. Katoh M., and Katoh M. Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. Cancer Biol. Ther. 5 (2006) 1059-1064
64. Mulholland D.J., et al. PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer. Oncogene 25 (2006) 329-337
65. Satyamoorthy K., et al. Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways. Cancer Res. 61 (2001) 7318-7324
66. Wang Y., et al. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res. 66 (2006) 11462-11470
67. Zhao H., et al. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis. Cancer Res. 65 (2005) 6864-6873
68. Laguë M.N., et al. Synergistic effects of Pten loss and WNT/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression. Carcinogenesis 29 (2008) 2062-2072
69. Boyer A., et al. Dysregulation of WNT/CTNNB1 and PI3K/AKT signaling in testicular stromal cells causes granulosa cell tumor of the testis. Carcinogenesis 30 (2009) 869-878
70. Fang D., et al. Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J. Biol. Chem. 282 (2007) 11221-11229
71. Sedding D.G. FoxO transcription factors in oxidative stress response and ageing-a new fork on the way to longevity?. Biol. Chem. 389 (2008) 279-283
72. Aoki M., et al. Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 13613-13617
73. Hoogeboom D., et al. Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity. J. Biol. Chem. 283 (2008) 9224-9230
74. Taurin S., et al. Phosphorylation of beta-catenin by PKA promotes ATP-induced proliferation of vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 294 (2008) C1169-1174
75. Taurin S., et al. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase. J. Biol. Chem. 281 (2006) 9971-9976
76. Osafune K., et al. Identification of multipotent progenitors in the embryonic mouse kidney by a novel colony-forming assay. Development 133 (2006) 151-161
77. Louis I., et al. The signaling protein Wnt4 enhances thymopoiesis and expands multipotent hematopoietic progenitors through beta-catenin-independent signaling. Immunity 29 (2008) 57-67
78. Canto P., et al. Mutation analysis of the WNT-4 gene in patients with polycystic ovary syndrome. Gynecol. Endocrinol. 22 (2006) 484-487
79. Hughes C., et al. Genomic and post-genomic approaches to polycystic ovary syndrome--progress so far: Mini Review. Hum. Reprod. 21 (2006) 2766-2775
80. Richards J.S. Hormonal control of gene expression in the ovary. Endocr. Rev. 15 (1994) 725-751
81. Richards J.S., et al. Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization. Recent Prog. Horm. Res. 57 (2002) 195-220
82. Conti M., et al. Role of the epidermal growth factor network in ovarian follicles. Mol. Endocrinol. 20 (2006) 715-723